McKesson Corporation (LON:0JZU)
Market Cap | 65.25B |
Revenue (ttm) | 277.90B |
Net Income (ttm) | 2.55B |
Shares Out | n/a |
EPS (ttm) | 19.91 |
PE Ratio | 25.58 |
Forward PE | 18.65 |
Dividend | 2.15 (0.31%) |
Ex-Dividend Date | Jun 2, 2025 |
Volume | 180 |
Average Volume | 251 |
Open | 677.19 |
Previous Close | 695.79 |
Day's Range | 668.20 - 683.00 |
52-Week Range | 335.28 - 700.76 |
Beta | 0.49 |
RSI | 42.16 |
Earnings Date | May 8, 2025 |
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ... [Read more]
Financial Performance
In 2024, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.
Financial numbers in USD Financial StatementsNews

Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
McKesson (NYSE: MCK) has outperformed the market over the past 15 years by 4.93% on an annualized basis producing an average annual return of 16.53%. Currently, McKesson has a market capitalization o...

Why McKesson Stock Bumped Modestly Higher Today

McKesson: Spin-Off Of Medical-Surgical Solutions Is A Positive, Strong Buy
McKesson is a Strong Buy with growth in oncology and biopharma, 19% revenue surge, and a focus on high-growth pharma markets. Read why MCK is a Strong Buy.
McKesson projects $36.75-$37.55 EPS for fiscal 2026 with oncology and biopharma growth
McKesson Corporation 2025 Q4 - Results - Earnings Call Presentation
McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript

McKesson to spin off surgical supplies unit, forecasts strong annual profit
McKesson forecast fiscal 2026 profit largely above estimates on Thursday and said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug d...
McKesson to Spin Off Medical-Surgical Company
McKesson stock up on encouraging 2026 profit guidance
McKesson Non-GAAP EPS of $10.12 beats by $0.29, revenue of $90.8B misses by $3.4B

McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
McKesson Unusual Options Activity
Investors with significant funds have taken a bullish position in McKesson (NYSE: MCK), a development that retail traders should be aware of. This was brought to our attention today through our monit...

How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings
McKesson Corporation (NYSE: MCK) will release its fourth-quarter financial results after the closing bell on Thursday . Analysts expect the company to report quarterly earnings at $9.83 per share, up...

How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings
McKesson Corporation MCK will release its fourth-quarter financial results after the closing bell on Thursday.
Ontada Illuminates the Power of its Real-World Evidence to Improve Health Outcomes for People with Cancer at ISPOR 2025
Ontada researchers to present 14 data presentations at ISPOR 2025 including a podium presentation on distress thermometer screening in US oncology setting BOSTON — Ontada®, a McKesson business and lea...

McKesson Corporation Declares Quarterly Dividend
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE: MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on ...

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...

McKesson Shares Rise Nearly 1% After Key Signal
MCK moves higher through the session after Alert McKesson, Inc. (MCK) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics i...

McKesson Shares Rise Nearly 1% After Key Signal
MCK moves higher through the session after Alert

McKesson Unveils Precision Care Companion, Revolutionizing Precision Medicine in Community Oncology
IRVING, Texas--(BUSINESS WIRE)--McKesson launched an initiative addressing the clinical challenges and administrative burden practices face in the era of biomarker-directed care.

These 20 stocks have risen during Trump's trade tirade. Analysts see up to 30% additional upside.
The stock market doesn't react well to uncertainty. And the daily headlines about new tariffs being placed on U.S. imports and possible negotiations with trading partners to do away with tariffs have ...

Registration Opens for Annual McKesson ideaShare Conference
IRVING, Texas--(BUSINESS WIRE)--Register to attend McKesson ideaShare, a premier community pharmacy annual education and networking event, in Nashville from July 10-13, 2025.

Sit Out The Crash With These 5 Dividend Stocks
Stocks plummeted by more than 10% last week after President Trump unveiled his new ‘reciprocal' tariff chart, with some heavy importers like Kohl's, Five Below, and Wayfair falling more than 20% on th...

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock
The S&P 500's three top performers in 2025 boast characteristics that could help them weather a further sell off.

McKesson Shares Up Over 2% After Key Signal
MCK IS UP OVER 14 POINTS AFTER THE TRADEPULSE ALERT Mckesson Inc. (MCK) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics...